Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

NCT07386912 is registered in ClinicalTrials.gov with Research Center Borstel as lead sponsor.

NCT NCT07386912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -
Lead sponsor
Research Center Borstel
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
December 31, 2030
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, bacterial pneumonia, copd, tuberculosis, viral pneumonia